The relationship between the biotechnology industry and the pharmaceutical industry in the pharmaceutical industry.

First, the pharmaceutical biotechnology industry is the most important component of the biotechnology industry Biotechnology industry, including pharmaceutical biotechnology industry, industrial biotechnology industry, agricultural biotechnology industry and marine biotechnology industry.
pharmaceutical biotechnology industry is the most important component of the biotechnology industry, accounting for more than 60% of the biotechnology industry, and biotechnology in pharmaceutical technology is also the most mature application.
Second, the proportion of pharmaceutical biotechnology industry in the pharmaceutical industry will be increasing at present, the output value of pharmaceutical biotechnology products (including genetic engineering drugs, vaccines, biodiagnostic reagents, etc.) in the pharmaceutical industry accounted for less than 10%, but due to the increasing difficulty of traditional new drug research and development methods, research and development costs continue to rise, the success rate is getting lower and lower.
, 70 per cent of the world's largest pharmaceutical companies currently use biotechnology for development.
the completion of the Human Genome Project, more new drugs made from biotechnology are expected to be available by 2010.
21st century, the entire pharmaceutical industry is facing the use of biotechnology for renewal.
Technology platform general third, technology platform versatility although biological medicine and chemical drugs, Traditional Chinese medicine sources are different, but the research and development process needs many technical platforms, such as animal centers, safety evaluation centers, pharmacological physiosology research centers, structural testing centers, chemical drug pilot workshops, biopharmaceutical pilot workshops, Chinese medicine testing workshops, clinical pharmacological research bases, medical device testing centers, etc.
, combining the biotechnology industry with the pharmaceutical industry can make full use of the general technology platform, reasonably share relevant resources and promote the common development of the two industries.
.